Warren Hosseinion
CIK: 0001438327
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 10, 2026VRXA
Veraxa Biotech AG
Purchase(P)Direct6K shares at avg. $1.67$10K - Mar 19, 2026NUTX
Nutex Health Inc.
Purchase(P)Direct252 shares at avg. $94.07$24K - Mar 10, 2026NUTX
Nutex Health Inc.
Exercise(M)DirectRestricted Stock Units
3.7K shares- - Mar 10, 2026NUTX
Nutex Health Inc.
Tax Payment(F)Direct3.3K shares at avg. $86.22$282K - Mar 10, 2026NUTX
Nutex Health Inc.
Exercise(M)Direct6.3K shares- - Apr 4, 2025NUTX
Nutex Health, Inc.
Tax Payment(F)Direct1.1K shares at avg. $72.10$77K - Mar 10, 2025NUTX
Nutex Health, Inc.
Exercise(M)DirectRestricted Stock Units
7.6K shares- - Mar 1, 2025NUTX
Nutex Health, Inc.
Exercise(M)Direct3.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 10, 2026 |  VRXA Veraxa Biotech AG | Purchase(P) | 6,024 | $1.67 | $10,060 | Direct |
| Mar 19, 2026 |  NUTX Nutex Health Inc. | Purchase(P) | 252 | $94.07 | $23,706 | Direct |
| Mar 10, 2026 | NUTX Nutex Health Inc. | Exercise(M) Restricted Stock Units | 3,656 | - | - | Direct |
| Mar 10, 2026 | NUTX Nutex Health Inc. | Tax Payment(F) | 3,274 | $86.22 | $282,292 | Direct |
| Mar 10, 2026 | NUTX Nutex Health Inc. | Exercise(M) | 6,293 | - | $0 | Direct |
| Apr 4, 2025 | NUTX Nutex Health, Inc. | Tax Payment(F) | 1,072 | $72.10 | $77,288 | Direct |
| Mar 10, 2025 | NUTX Nutex Health, Inc. | Exercise(M) Restricted Stock Units | 7,551 | - | - | Direct |
| Mar 1, 2025 | NUTX Nutex Health, Inc. | Exercise(M) | 3,776 | - | - | Direct |
1-8 of 8 transactions
About Hosseinion Warren
Hosseinion Warren (SEC CIK 0001438327) files insider reports with the SEC as Director of Veraxa Biotech AG (VRXA), Director of Veraxa Biotech Holding AG (VRXA) and President of Nutex Health Inc. (NUTX). Signal8 also holds filings tied to 1 other company.
Signal8 holds 6 ownership filings by Hosseinion Warren (2 Form 3, 4 Form 4), filed between Apr 14, 2025 and Sep 29, 2026. Those filings report 8 transactions, from Mar 1, 2025 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hosseinion Warren's filings is in ZURICH,.
Recent filings by Hosseinion Warren
- Sep 10, 2026: Open-market purchase of VRXA shares (Form 4, code P).
- Mar 19, 2026: Open-market purchase of NUTX shares (Form 4, code P).
- Mar 10, 2026: Option exercise of NUTX derivative securities (Form 4, code M).
- Mar 10, 2026: Tax withholding of NUTX shares (Form 4, code F).
- Mar 10, 2026: Option exercise of NUTX shares (Form 4, code M).
Other insiders filing for Veraxa Biotech AG (VRXA)
- Gruninger Marc, Director
- Ziegler Christoph Samuel, Director
- Willener Raju Sudir, Chief Financial Officer
- von Halem Carl, Interim CFO
- Baumann Oliver Rolf, Director
- Antz Christoph Rudiger, Chief Executive Officer